M.D.
Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
Heidelberg, Baden-Wurttemberg, Germany
Elias K. Mai received his medical degree (MD) from the University of Heidelberg in 2012. Since then, he has been working as a resident physician at the Department of Internal Medicine V (Hematology, Oncology and Rheumatology) and German-speaking Myeloma Multicenter Group (GMMG) at the Heidelberg University Hospital, Germany. In 2022, he completed his habilitation in internal medicine on innovative treatment options and prognostic tools for patients with newly diagnosed multiple myeloma. EliasĀ“ research activities focus on multiple myeloma and its precursor diseases. His ongoing research focuses on clinical trials in newly diagnosed myeloma, relapsed/refractory myeloma, smoldering myeloma and translational activities investigating mechanisms of drug resistance and highly sensitive monitoring of myeloma disease (mass spectrometry and minimal residual disease).
Elias has published several research articles in high-ranking scientific journals (JCO, Lancet Haematology, Blood, Leukemia) and serves as a reviewer for several journals. He has presented his research findings at national and international conferences, and cooperates with well-known international partners and study groups. In 2021, he was awarded the International Myeloma Society Career Development Award, which he used for a research visit at the Roswell Park Comprehensive Cancer Center (Prof. J. Hillengass), Buffalo, NY, USA and the Mayo Clinic (Prof. S. Kumar), Rochester, MN, USA.
Disclosure information not submitted.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Friday, September 27, 2024
8:20 AM – 8:35 AM East Coast USA Time
Friday, September 27, 2024
8:55 AM – 9:00 AM East Coast USA Time